Proteomics

Dataset Information

0

Proteomic Analysis Reveal Myometrial Fibrosis of Adenomyosis(Human,adenomyosis,tissue,LC-MSMS)


ABSTRACT: Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was utilized to analyze adenomyotic and normal myometrial tissues from ten AM patients who underwent hysterectomy with myometrial fibrosis confirmed by Masson staining. This analysis established comprehensive proteomic profiles of adenomyosis patients and revealed widespread alterations in the proteome and metabolome within normal and fibrotic myometrium. Key proteins and signaling pathways linked to myometrial fibrogenesis were identified based on proteomic data.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Uterus

DISEASE(S): Endometriosis Of Uterus

SUBMITTER: Qiaomei Yang  

LAB HEAD: Mao Xiaodan

PROVIDER: PXD058989 | Pride | 2025-05-07

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
Codex.xlsx Xlsx
Database.search.result.zip Other
Original-data.zip Other
checksum.txt Txt
Items per page:
1 - 4 of 4
altmetric image

Publications

Integrated multi-omics analysis and experimental verification reveal the involvement of the PI3K/Akt signaling pathway in myometrial fibrosis of adenomyosis.

Yang Qiaomei Q   Hong Jingxuan J   Fu Jianhui J   Liu Xianhua X   Zheng Xinye X   Jiang Junying J   Zhu An A   Chen Li L   Lin Hao H   Sun PengMing P  

Scientific reports 20250420 1


Adenomyosis (AM) is characterized as a chronic and progressive disorder with limited therapeutic strategies available. Myometrial fibrosis is a prominent pathological feature of AM, yet the underlying molecular mechanisms remain elusive. The present study conducted a comparative analysis using proteomics and metabolomics to investigate myometrial fibrosis and its underlying mechanisms. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was utilized to analyze adenomyotic and normal myomet  ...[more]

Similar Datasets

2025-05-06 | PXD041139 | Pride
2025-02-04 | PXD060212 | Pride
2021-09-24 | PXD027906 | Pride
2021-09-09 | PXD020047 | Pride
2025-01-24 | PXD058194 | Pride
2023-08-07 | PXD043085 | Pride
2024-04-29 | PXD048142 | Pride
2020-03-20 | PXD013908 | Pride
2021-05-12 | PXD022525 | Pride
2023-12-01 | PXD045984 | Pride